Among them, CENPA (Mullen et al., 2020), DNMT1 (Wu et al., 2020), MYBL2 (Mullen et al., 2020), TFDP1 (Zhan et al., 2017), ZNF367 (Liu Z. et al., 2018), HMGA1 (Zhang Z. et al., 2015), HMGA2 (Gao et al., 2018), and FOXM1 (Mullen et al., 2020) were previously shown to be highly associated with NSCLC progression. Here, FOXM1 is linked to non-small cell lung carcinoma.